Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr. Reddys Laboratories informs about press release
Date: 24-12-2018Dr. Reddys Laboratories has informed about press release titled ‘Dr. Reddy's Laboratories launches Aspirin and Extended-Release Dipyridamole Capsules in the US Market.’
The above information is a part of company’s filings submitted to BSE.